CD1D and osteosarcoma: Furthermore, human iNKT cells have been reported to kill CD1d+ osteosarcoma cells, but not CD1d− osteoblasts, confirming the CD1d restriction of iNKT cell–dependent cytotoxicity (Fallarini et al., 2012).